INCY Incyte Corporation - Common Stock
$127,56
Prix · Aoû 21, 2026
Données fondamentales au Jul 28, 2026
Fourchette 52 semaines
$81–$133
90% of range
Note des analystes
HOLD
33 analysts
Objectif de cours
$125
P/E (TTM)
19.9
ROE
27.6%
Marge nette
25.0%
À propos de Incyte Corporation - Common Stock Présentation de l'entreprise depuis Wikipedia
Incyte est une société pharmaceutique américaine basée à Alapocas, au Delaware. L'entreprise a été fondée à Palo Alto, Californie, en 1991 et a été introduite en bourse en 1993.
Lire la suite
Incyte est une société pharmaceutique américaine basée à Alapocas, au Delaware. L'entreprise a été fondée à Palo Alto, Californie, en 1991 et a été introduite en bourse en 1993.
Incyte a développé un médicament, le Jakafi (ruxolitinib), qui a été approuvé par la Food and Drug Administration (FDA) des États-Unis et qui a été prescrit à plusieurs milliers de patients aux États-Unis.
## Historique
À compter de 2014, la société mettait au point le baricitinib, un inhibiteur oral du JAK1 et du JAK2 contre la polyarthrite rhumatoïde, en partenariat avec Eli Lilly. Il a été approuvé par l'Union européenne en février 2017. En avril 2017, la Food and Drug Administration des États-Unis a émis un avis de rejet, invoquant des préoccupations au sujet de la posologie et de l'innocuité.
À partir de 2016, un inhibiteur de l'indoléamine 2,3-dioxygénase (IDO1), était en développement pour soigner divers cancers et faisait l'objet d'essais combinés avec le pembrolizumab (Keytruda) de Merck et le nivolumab (Opdivo) de Bristol Myers Squibb.
En 2014, Incyte nomme Hervé Hoppenot Président-directeur général. Hoppenot avait précédemment été président de Novartis Oncologie.
En septembre 2015, la société a annoncé qu'elle avait obtenu le droit exclusif de développement et de commercialisation de l'anticorps monoclonal anti-PD-1 SHR-1210 de Jiangsu Hengrui Medicine Co, Ltd. dans le cadre d'une transaction d'une valeur de plus de 795 millions de dollars.
En mars 2018, Incyte lance la construction de son siège européen à Morges.
== Références ==
Source : Wikipedia, CC BY-SA 4.0 · Voir sur Wikipedia ↗
INCY Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$127.56
Capitalisation Boursière
$25.31B
P/E (TTM)
19.9
BPA (TTM)
$6.41
Revenus (TTM)
$5.14B
Rendement div.
—
ROE
27.6%
Dette/Capitaux propres
—
Fourchette 52 semaines
$81 – $133
INCY Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$5.14B
2016-12-31
→
2025-12-31
BPA
$6.41
2016-12-31
→
2025-12-31
Flux de trésorerie libre
—
2017-12-31
→
2022-12-31
Marges
25.0%
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
INCY
Médiane des pairs
P/E (TTM)
19.9
17.7
P/S (TTM)
4.9
6.8
P/B
4.9
6.4
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
INCY
Médiane des pairs
Operating Margin (Marge d'exploitation)
29.5%
—
Net Profit Margin (Marge nette)
25.0%
20.3%
ROA
20.8%
11.4%
ROE
27.6%
16.8%
ROIC
22.7%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
INCY
Médiane des pairs
Current Ratio (Ratio de liquidité)
3.3
3.4
Quick Ratio (Ratio de liquidité réduite)
2.0
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
INCY
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
21.2%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
14.8%
—
Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans)
14.0%
—
EPS YoY (BPA Année/Année)
4173.3%
—
Net Income YoY (Bénéfice net YoY)
3845.0%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
INCY
Médiane des pairs
INCY Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
33 analystes
- Achat fort 8 24,2%
- Achat 9 27,3%
- Conserver 16 48,5%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
23 analystes · 2026-08-18
Médiane
$120.00
Maintenant
$127.56
Bas
$86.00
Haut
$155.00
Objectif médian
$120.00
-5,9%
Objectif moyen
$125.17
-1,9%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.33%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $3.09 | $2.14 | 0.95% |
| 31 mars 2026 | $1.81 | $1.40 | 0.41% |
| 31 décembre 2025 | $1.80 | $1.97 | -0.17% |
| 30 septembre 2025 | $2.26 | $1.69 | 0.57% |
| 30 juin 2025 | $1.57 | $1.50 | 0.07% |
| 31 mars 2025 | $1.16 | $1.04 | 0.12% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| INCY | $19.60B | 15.4 | 21.2% | 25.0% | 27.6% | — |
| NTRA | $32.00B | -150.7 | 35.9% | -9.0% | -14.1% | — |
| RVMD | — | — | — | — | — | — |
| BIIB | $25.84B | 20.0 | 2.2% | 13.1% | 7.2% | — |
| ALNY | $52.64B | 170.7 | 65.2% | 8.5% | 60.4% | — |
| INSM | $37.29B | -27.1 | 66.7% | -210.5% | -128.4% | — |
| UTHR | $21.27B | 17.5 | 10.6% | 41.9% | 18.7% | 87.9% |
| BBIO | $14.90B | -20.2 | 126.3% | -146.0% | 41.2% | — |
| NBIX | $14.20B | 30.4 | 21.4% | 16.7% | 16.1% | — |
| EXEL | $11.44B | 15.7 | 7.0% | 33.7% | 37.3% | — |
| BMRN | $11.43B | 33.0 | 12.9% | 10.8% | 5.8% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 17
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.14B | $4.24B | $3.70B | $3.39B | $2.99B | $2.67B | $2.16B | $1.88B | $1.54B | $1.11B | $754M | $511M | |
| Cost of Revenue | $372M | $312M | $255M | $207M | $151M | $131M | $114M | $94M | $79M | $58M | $27M | $3M | |
| R&D Expense | $2.05B | $2.61B | $1.63B | $1.59B | $1.46B | $2.22B | $1.15B | $1.20B | $1.33B | $582M | $480M | $348M | |
| SG&A Expense | $1.38B | $1.24B | $1.16B | $1.00B | $740M | $517M | $469M | $434M | $366M | $303M | $197M | $166M | |
| Operating Expenses | $3.63B | $4.18B | $3.08B | $2.82B | $2.40B | $2.93B | $1.76B | $1.75B | $1.78B | $961M | $703M | $516M | |
| Operating Income | $1.51B | $61M | $621M | $579M | $586M | $-264M | $402M | $129M | $-243M | $145M | $51M | $-5M | |
| Interest Expense | · | · | $3M | $3M | $2M | $2M | $2M | $2M | $7M | $39M | $46M | $47M | |
| Interest Income | $106M | $129M | $158M | $40M | · | · | · | · | · | · | · | · | |
| Other Non-op | $25M | $13M | $14M | $-519.0K | $11M | $23M | $52M | $32M | $17M | · | · | · | |
| Pretax Income | $1.66B | $317M | $834M | $529M | $570M | $-232M | $487M | $115M | $-312M | $107M | $8M | $-49M | |
| Income Tax | $378M | $284M | $237M | $188M | $-378M | $63M | $40M | $6M | $852.0K | $3M | $1M | $-66.0K | |
| Net Income | $1.29B | $33M | $598M | $341M | $949M | $-296M | $447M | $109M | $-313M | $104M | · | · | |
| EPS (Basic) | $6.59 | $0.16 | $2.67 | $1.53 | $4.30 | $-1.36 | $2.08 | $0.52 | $-1.53 | $0.55 | $0.04 | $-0.29 | |
| EPS (Diluted) | $6.41 | $0.15 | $2.65 | $1.52 | $4.27 | $-1.36 | $2.05 | $0.51 | $-1.53 | $0.54 | $0.03 | $-0.29 | |
| Shares (Basic) | 195,204,000 | 207,110,000 | 223,628,000 | 222,004,000 | 220,428,000 | 218,073,000 | 214,913,000 | 212,383,000 | 204,580,000 | 187,873,000 | 179,601,000 | 167,947,000 | |
| Shares (Diluted) | 200,700,000 | 210,530,000 | 225,928,000 | 223,958,000 | 222,074,000 | 218,073,000 | 217,657,000 | 215,635,000 | 204,580,000 | 194,125,000 | 187,302,000 | 167,947,000 | |
| EBITDA | $1.61B | $151M | · | $647M | $644M | $-212M | $457M | $184M | $-192M | · | · | $37M |
Bilan 27
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.10B | $1.69B | $3.21B | $2.95B | $2.06B | $1.51B | $1.83B | $1.16B | $900M | $652M | $521M | $452M | |
| Short-term Investments | · | · | · | · | · | · | $285M | $274M | $270M | $156M | $186M | $148M | |
| Inventory | $101M | $59M | $63M | $42M | $28M | $16M | $11M | $7M | $6M | $4M | $2M | $358.0K | |
| Prepaid Expense | $318M | $169M | $183M | $167M | $126M | $60M | $44M | $79M | $62M | $33M | $18M | $21M | |
| Current Assets | $5.02B | $3.24B | $4.65B | $4.09B | $3.12B | $2.36B | $2.48B | $1.83B | $1.50B | $994M | $842M | $680M | |
| PP&E (Net) | $731M | $763M | $752M | $739M | $724M | $560M | $378M | $320M | $260M | $168M | $86M | $82M | |
| PP&E (Gross) | $1.11B | $1.09B | $1.02B | $952M | $900M | $704M | $499M | $423M | $334M | $219M | $131M | $116M | |
| Accum. Depreciation | $375M | $328M | $270M | $213M | $176M | $144M | $122M | $103M | $75M | $52M | $45M | $35M | |
| Goodwill | $133M | $156M | $156M | $156M | $156M | $156M | $156M | $156M | $156M | $156M | · | · | |
| Intangibles | · | · | · | · | · | · | · | · | $237M | $270M | $12M | $2M | |
| Other Non-current Assets | $18M | $11M | $52M | $25M | $37M | $39M | $49M | $19M | $2M | $3M | $12M | · | |
| Total Assets | $6.96B | $5.44B | $6.78B | $5.84B | $4.93B | $3.56B | $3.43B | $2.65B | $2.30B | $1.64B | $1.01B | $796M | |
| Accounts Payable | $210M | $197M | $110M | $278M | $172M | $99M | $84M | $104M | $68M | $76M | $30M | $24M | |
| Accrued Liabilities | $1.03B | $1.21B | $936M | $701M | $534M | $378M | $286M | $229M | $199M | $127M | $87M | $62M | |
| Current Liabilities | $1.52B | $1.64B | $1.24B | $1.16B | $854M | $631M | $513M | $425M | $375M | $274M | $168M | $221M | |
| Capital Leases | $15M | $17M | $14M | $14M | $16M | $14M | $12M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $20M | |
| Other Non-current Liabilities | $165M | $168M | $149M | $99M | $70M | $58M | $40M | $22M | $20M | $13M | $48M | $55M | |
| Total Liabilities | $1.79B | $2.00B | $1.59B | $1.47B | $1.16B | $950M | $828M | $720M | $672M | $1.22B | $836M | $878M | |
| Long-term Debt | · | · | · | · | · | · | · | $19.09B | $27M | $750M | $750M | $841M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $689M | |
| Common Stock | $198.0K | $193.0K | $224.0K | $223.0K | $221.0K | $219.0K | $216.0K | $213.0K | $211.0K | $189.0K | $187.0K | $171.0K | |
| Retained Earnings | $214M | $-1.07B | $160M | $-437M | $-778M | $-1.73B | $-1.43B | $-1.88B | $-1.99B | $-1.67B | $-1.78B | $-1.79B | |
| AOCI | $25M | $-13M | $13M | $15M | $-19M | $-15M | $-16M | $-10M | $-7M | $-3M | $-809.0K | $2M | |
| Stockholders' Equity | $5.17B | $3.45B | $5.19B | $4.37B | $3.77B | $2.61B | $2.60B | $1.93B | $1.63B | $419M | $171M | $-82M | |
| Liabilities + Equity | $6.96B | $5.44B | $6.78B | $5.84B | $4.93B | $3.56B | $3.43B | $2.65B | $2.30B | $1.64B | $1.01B | $796M | |
| Shares Outstanding | 198,460,009 | 193,434,305 | 224,286,862 | 222,746,719 | 221,084,433 | 219,489,329 | 216,177,830 | 213,274,660 | 211,262,906 | 188,848,752 | 186,650,249 | 170,876,619 |
Flux de trésorerie 16
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $93M | $89M | $83M | $68M | $58M | $52M | $55M | $55M | $52M | $58M | $45M | $41M | |
| Stock-based Comp | $249M | $266M | $216M | $188M | $183M | $178M | $167M | $148M | $133M | $96M | $70M | $62M | |
| Deferred Tax | $248M | $-86M | $-159M | $57M | $-466M | $-350.0K | $-377.0K | $-459.0K | $-805.0K | · | · | · | |
| Amort. of Intangibles | $27M | $24M | $22M | $22M | $22M | $22M | $22M | $22M | $22M | $13M | · | · | |
| Other Non-cash | $-463M | $33M | · | $316M | $26M | $-58M | $43M | $24M | · | · | · | · | |
| Operating Cash Flow | $1.41B | $335M | $496M | $970M | $749M | $-125M | $711M | $336M | $-93M | $305M | $89M | $26M | |
| CapEx | · | · | · | $78M | $181M | $187M | $78M | $73M | $111M | $120M | $26M | $28M | |
| Investing Cash Flow | $-103M | $158M | $-208M | $-79M | $-208M | $-269M | $-87M | $-86M | $-350M | $-232M | $-105M | · | |
| Stock Issued | · | · | · | · | · | · | · | · | $649M | · | · | · | |
| Stock Repurchased | $0 | $2.00B | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $0 | $-2.00B | · | · | · | · | · | · | $649M | · | · | · | |
| Financing Cash Flow | $101M | $-2.02B | $-20M | $-794.0K | $6M | $72M | $46M | $15M | $690M | $45M | $85M | · | |
| Net Change in Cash | $1.41B | $-1.53B | $262M | $894M | $544M | $-319M | $669M | $265M | $247M | $117M | $69M | $-19M | |
| Taxes Paid | $212M | $373M | $378M | $136M | $68M | $71M | $34M | $5M | $6M | $927.0K | · | · | |
| Free Cash Flow | · | · | · | $892M | $568M | $-312M | $633M | $263M | $-204M | · | · | $-2M | |
| Levered FCF | · | · | · | $890M | $565M | $-315M | $631M | $261M | $-211M | · | · | $-48M |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 29.5% | 1.5% | · | 17.1% | 19.6% | -9.9% | 18.6% | 6.9% | -15.9% | · | · | -0.94% | |
| Net Margin | 25.0% | 0.77% | · | 10.0% | 31.8% | -11.1% | 20.7% | 5.8% | · | · | · | · | |
| Pretax Margin | 32.4% | 7.5% | · | 15.6% | 19.1% | -8.7% | 22.6% | 6.1% | -20.3% | · | · | -9.5% | |
| EBITDA Margin | 31.3% | 3.5% | · | 19.1% | 21.6% | -7.9% | 21.1% | 9.8% | -12.5% | · | · | 7.2% | |
| ROA | 20.8% | 0.53% | · | 6.3% | 22.3% | -8.5% | 14.7% | 4.4% | · | · | · | · | |
| ROE | 27.6% | 0.99% | · | 7.9% | 27.4% | -11.8% | 17.8% | 5.9% | · | · | · | · | |
| ROIC | 22.7% | 0.18% | · | 8.5% | 25.8% | -12.9% | 14.2% | 6.4% | -15.0% | · | · | -0.79% |
Liquidité et Solvabilité 4
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.3 | 2.0 | · | 3.5 | 3.7 | 3.7 | 4.8 | 4.3 | 4.0 | · | · | 3.2 | |
| Quick Ratio | 2.0 | 1.0 | · | 2.6 | 2.4 | 2.4 | 4.1 | 3.4 | 3.1 | · | · | 2.7 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | -8.4 | |
| Interest Coverage | · | · | · | 217.3 | 307.0 | -121.3 | 216.7 | 83.7 | -35.3 | · | · | -0.1 |
Efficacité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | · | 0.6 | 0.7 | 0.8 | 0.7 | 0.8 | 0.8 | · | · | 0.7 | |
| Inventory Turnover | 4.7 | 5.1 | · | 5.9 | 6.8 | 9.4 | 12.4 | 14.0 | 15.0 | · | · | 7.9 |
Taux de croissance 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 21.2% | 14.8% | 8.9% | 13.7% | 12.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 14.8% | 12.4% | 11.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 14.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 4173.3% | -94.3% | 74.3% | -64.4% | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 61.6% | -67.2% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 3845.0% | -94.5% | 75.4% | -64.1% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 55.7% | -67.5% | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5.14B | $4.24B | $3.70B | $3.39B | $2.99B | $2.67B | $2.16B | $1.88B | $1.54B | $1.11B | $754M | $511M | |
| Net Income TTM | $1.29B | $33M | $598M | $341M | $949M | $-296M | $447M | $109M | $-313M | $104M | · | · | |
| Market Cap | $19.60B | $13.36B | · | $17.89B | $16.23B | $19.09B | $18.88B | $13.56B | $20.01B | · | · | · | |
| P/E | 15.4 | 460.5 | 23.7 | 52.8 | 17.2 | -64.0 | 42.6 | 124.7 | -61.9 | 185.7 | 3615.0 | -252.1 | |
| P/S | 3.8 | 3.2 | · | 5.3 | 5.4 | 7.2 | 8.7 | 7.2 | 13.0 | · | · | · | |
| P/B | 3.8 | 3.9 | · | 4.1 | 4.3 | 7.3 | 7.3 | 7.0 | 12.3 | · | · | · | |
| P / Tangible Book | 3.9 | 4.1 | 2.8 | 4.2 | 4.5 | 7.8 | · | · | · | · | · | · | |
| P / Cash Flow | 13.9 | 39.8 | · | 18.4 | 21.7 | -153.2 | 26.6 | 40.3 | -215.2 | · | · | · | |
| P / FCF | · | · | · | 20.1 | 28.5 | -61.2 | 29.8 | 51.6 | -98.1 | · | · | · | |
| Earnings Yield | 6.5% | 0.22% | 4.2% | 1.9% | 5.8% | -1.6% | 2.4% | 0.80% | -1.6% | 0.54% | 0.03% | -0.40% |
Compte de résultat 17
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.67B | $1.27B | $1.51B | $1.37B | $1.22B | $1.05B | $1.18B | $1.14B | $1.04B | $881M | $1.01B | $919M | $955M | $809M | $927M | $823M | |
| Cost of Revenue | $105M | $105M | $121M | $99M | $79M | $73M | $88M | $86M | $77M | $61M | $70M | $60M | $68M | $57M | $59M | $55M | |
| R&D Expense | $517M | $516M | $611M | $507M | $495M | $437M | $466M | $573M | $1.14B | $429M | $444M | $376M | $401M | $407M | $501M | $384M | |
| SG&A Expense | $352M | $328M | $390M | $329M | $331M | $326M | $327M | $309M | $306M | $300M | $288M | $268M | $284M | $316M | $273M | $266M | |
| Operating Expenses | $976M | $972M | $1.17B | $922M | $685M | $848M | $877M | $992M | $1.52B | $789M | $826M | $704M | $761M | $784M | $857M | $685M | |
| Operating Income | $698M | $301M | $336M | $444M | $530M | $205M | $302M | $146M | $-478M | $92M | $187M | $215M | $194M | $25M | $70M | $138M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $430.0K | · | $623.0K | $655.0K | $469.0K | · | $641.0K | |
| Interest Income | $38M | $34M | $31M | $27M | $25M | $23M | $21M | $19M | $41M | $47M | · | · | · | · | · | · | |
| Other Non-op | $6M | $3M | $6M | $4M | $7M | $8M | $2M | $5M | $8M | $-2M | $-108M | $46M | $43M | $33M | $-14M | $12M | |
| Pretax Income | $752M | $344M | $390M | $482M | $558M | $234M | $314M | $157M | $-390M | $236M | $271M | $234M | $278M | $52M | $81M | $149M | |
| Income Tax | $166M | $40M | $91M | $58M | $153M | $76M | $113M | $50M | $55M | $67M | $70M | $63M | $74M | $30M | $52M | $36M | |
| Net Income | $586M | $303M | $299M | $424M | $405M | $158M | $201M | $106M | $-445M | $170M | $201M | $171M | $204M | $22M | $28M | $113M | |
| EPS (Basic) | $2.92 | $1.52 | $1.51 | $2.17 | $2.09 | $0.82 | $0.89 | $0.55 | $-2.04 | $0.76 | $0.90 | $0.76 | $0.91 | $0.10 | $0.12 | $0.51 | |
| EPS (Diluted) | $2.81 | $1.47 | $1.46 | $2.11 | $2.04 | $0.80 | $0.90 | $0.54 | $-2.04 | $0.75 | $0.89 | $0.76 | $0.90 | $0.10 | $0.13 | $0.50 | |
| Shares (Basic) | 200,378,000 | 199,343,000 | -388,173,000 | 195,670,000 | 193,995,000 | 193,712,000 | -428,178,000 | 192,629,000 | 218,175,000 | 224,484,000 | -446,658,000 | 224,078,000 | 223,248,000 | 222,960,000 | -443,397,000 | 222,415,000 | |
| Shares (Diluted) | 208,216,000 | 206,830,000 | -397,670,000 | 201,429,000 | 198,744,000 | 198,197,000 | -430,702,000 | 195,838,000 | 218,175,000 | 227,219,000 | -451,477,000 | 226,167,000 | 225,649,000 | 225,589,000 | -446,828,000 | 224,175,000 | |
| EBITDA | $698M | $325M | · | $444M | $530M | $228M | · | $146M | $-478M | $114M | · | $215M | $194M | $44M | · | $138M |
Bilan 22
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.98B | $3.46B | $3.10B | $2.46B | $1.95B | $1.94B | $1.69B | $1.30B | $987M | $3.35B | · | $3.23B | $3.13B | $2.82B | · | $2.69B | |
| Inventory | $113M | $116M | $101M | $83M | $83M | $64M | $59M | $70M | $101M | $64M | · | $57M | $36M | $41M | · | $46M | |
| Prepaid Expense | $253M | $301M | $318M | $369M | $296M | $212M | $169M | $205M | $208M | $189M | · | $172M | $167M | $194M | · | $180M | |
| Current Assets | $6.03B | $5.48B | $5.02B | $4.28B | $3.64B | $3.51B | $3.24B | $2.81B | $2.57B | $4.85B | · | $4.40B | $4.26B | $3.97B | · | $3.82B | |
| PP&E (Net) | $709M | $720M | $731M | $799M | $799M | $765M | $763M | $773M | $762M | $720M | · | $733M | $749M | $742M | · | $716M | |
| PP&E (Gross) | $1.11B | $1.11B | $1.11B | $1.16B | $1.14B | $1.11B | $1.09B | $1.09B | $1.06B | $1.00B | · | $986M | $988M | $967M | · | $918M | |
| Accum. Depreciation | $404M | $389M | $375M | $361M | $346M | $344M | $328M | $316M | $298M | $283M | · | $253M | $239M | $226M | · | $202M | |
| Goodwill | $133M | $133M | $133M | $156M | $156M | $156M | $156M | $156M | $156M | $156M | · | $156M | $156M | $156M | · | $156M | |
| Other Non-current Assets | $87M | $24M | $18M | $32M | $33M | $30M | $11M | $40M | $22M | $47M | · | $81M | $32M | $21M | · | $24M | |
| Total Assets | $7.87B | $7.34B | $6.96B | $6.33B | $5.82B | $5.75B | $5.44B | $5.01B | $4.66B | $7.14B | · | $6.39B | $6.21B | $5.80B | · | $5.51B | |
| Accounts Payable | $250M | $229M | $210M | $172M | $241M | $196M | $197M | $179M | $148M | $164M | · | $139M | $156M | $56M | · | $163M | |
| Accrued Liabilities | $870M | $1.09B | $1.03B | $948M | $857M | $1.38B | $1.21B | $1.13B | $1.03B | $1.10B | · | $821M | $811M | $825M | · | $700M | |
| Current Liabilities | $1.31B | $1.49B | $1.52B | $1.34B | $1.28B | $1.72B | $1.64B | $1.50B | $1.34B | $1.40B | · | $1.12B | $1.12B | $1.01B | · | $1.01B | |
| Capital Leases | · | · | $15M | · | · | · | $17M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $125M | $127M | $165M | $171M | $180M | $176M | $168M | $145M | $142M | $151M | · | $133M | $140M | $118M | · | $75M | |
| Total Liabilities | $1.53B | $1.72B | $1.79B | $1.68B | $1.65B | $2.08B | $2.00B | $1.84B | $1.66B | $1.74B | · | $1.46B | $1.47B | $1.34B | · | $1.28B | |
| Common Stock | $201.0K | $200.0K | $198.0K | $196.0K | $194.0K | $193.0K | $193.0K | $192.0K | $191.0K | $224.0K | · | $224.0K | $223.0K | $223.0K | · | $222.0K | |
| Retained Earnings | $1.10B | $517M | $214M | $-86M | $-510M | $-915M | $-1.07B | $-1.27B | $-1.38B | $330M | · | $-41M | $-212M | $-416M | · | $-466M | |
| AOCI | $20M | $22M | $25M | $15M | $13M | $-6M | $-13M | $16M | $-5M | $-6M | · | $23M | $27M | $21M | · | $-29M | |
| Stockholders' Equity | $6.34B | $5.62B | $5.17B | $4.65B | $4.17B | $3.67B | $3.45B | $3.17B | $3.00B | $5.39B | $5.19B | $4.93B | $4.74B | $4.46B | $4.37B | $4.23B | |
| Liabilities + Equity | $7.87B | $7.34B | $6.96B | $6.33B | $5.82B | $5.75B | $5.44B | $5.01B | $4.66B | $7.14B | · | $6.39B | $6.21B | $5.80B | · | $5.51B | |
| Shares Outstanding | 200,977,687 | 199,948,401 | 198,460,009 | 196,130,993 | 194,123,265 | 193,783,446 | 193,434,305 | 192,798,328 | 191,572,449 | 224,533,449 | · | 224,101,839 | 223,338,330 | 223,061,787 | · | 222,454,839 |
Flux de trésorerie 10
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $26M | $24M | $24M | $24M | $23M | $22M | $23M | $23M | $22M | $22M | $22M | $21M | $20M | $19M | $18M | $17M | |
| Stock-based Comp | $67M | $64M | $62M | $62M | $65M | $61M | $72M | $78M | $57M | $60M | $60M | $48M | $55M | $53M | $53M | $45M | |
| Other Non-cash | · | $-22M | · | · | · | $25M | · | · | · | $-32M | · | · | · | $-200M | · | · | |
| Operating Cash Flow | $508M | $369M | $543M | $559M | $45M | $266M | $381M | $311M | $-576M | $219M | $148M | $148M | $307M | $-106M | $284M | $296M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $28M | |
| Investing Cash Flow | $-52M | $-88M | $-37M | $-47M | $-19M | $1M | $-21M | $38M | $214M | $-73M | $-154M | $-17M | $-7M | $-29M | $-21M | $-28M | |
| Stock Repurchased | · | · | $0 | $0 | · | · | $0 | $103.0K | · | · | $0 | $0 | · | · | · | · | |
| Financing Cash Flow | $65M | $85M | $138M | $-13M | $-11M | $-13M | $20M | $-32M | $-2.00B | $-12M | $346.0K | $-37M | $13M | $4M | $-2M | $-14M | |
| Net Change in Cash | $521M | $363M | $643M | $500M | $13M | $254M | $384M | $317M | $-2.36B | $133M | $-14M | $96M | $310M | $-130M | $261M | $255M | |
| Taxes Paid | $15M | $-9M | $27M | $7M | $177M | $844.0K | $70M | $73M | $227M | $3M | $125M | $116M | $130M | $7M | $20M | $40M |
Rentabilité 7
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 41.7% | 23.7% | · | 32.5% | 43.6% | 19.5% | · | 12.8% | -45.8% | 10.4% | · | 23.4% | 20.3% | 3.1% | · | 16.8% | |
| Net Margin | 35.0% | 23.8% | · | 31.1% | 33.3% | 15.0% | · | 9.4% | -42.6% | 19.2% | · | 18.6% | 21.3% | 2.7% | · | 13.7% | |
| Pretax Margin | 44.9% | 27.0% | · | 35.3% | 45.9% | 22.2% | · | 13.8% | -37.3% | 26.8% | · | 25.4% | 29.1% | 6.4% | · | 18.1% | |
| EBITDA Margin | 41.7% | 25.5% | · | 32.5% | 43.6% | 21.6% | · | 12.8% | -45.8% | 12.9% | · | 23.4% | 20.3% | 5.4% | · | 16.8% | |
| ROA | 8.6% | 4.6% | · | 7.5% | 7.7% | 2.5% | · | 1.9% | -8.2% | 2.6% | · | 2.9% | 3.5% | 0.40% | · | 2.3% | |
| ROE | 11.1% | 6.5% | · | 10.8% | 11.3% | 3.5% | · | 2.6% | -11.5% | 3.4% | · | 3.7% | 4.6% | 0.52% | · | 3.1% | |
| ROIC | 8.6% | 4.7% | · | 8.4% | 9.2% | 3.8% | · | 3.1% | -18.2% | 1.2% | · | 3.2% | 3.0% | 0.23% | · | 2.5% |
Liquidité et Solvabilité 3
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | 3.7 | · | 3.2 | 2.8 | 2.0 | · | 1.9 | 1.9 | 3.5 | · | 3.9 | 3.8 | 3.9 | · | 3.8 | |
| Quick Ratio | 3.0 | 2.3 | · | 1.8 | 1.5 | 1.1 | · | 0.9 | 0.7 | 2.4 | · | 2.9 | 2.8 | 2.8 | · | 2.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 213.7 | · | 344.6 | 295.8 | 52.8 | · | 215.9 |
Efficacité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | |
| Inventory Turnover | 1.1 | 1.2 | · | 1.3 | 0.9 | 1.1 | · | 1.3 | 1.1 | 1.2 | · | 1.2 | 1.5 | 1.5 | · | 1.6 |
Valorisation (TTM) 9
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5.53B | $4.91B | · | $4.77B | $4.45B | $4.12B | · | $3.98B | $3.80B | $3.56B | · | $3.51B | $3.50B | $3.28B | · | $3.28B | |
| Net Income TTM | $1.72B | $1.29B | · | $1.09B | $225M | $-10M | · | $3M | $100M | $566M | · | $509M | $499M | $334M | · | $494M | |
| Market Cap | $22.78B | $18.82B | · | $16.63B | $13.22B | $11.73B | · | $12.74B | $11.61B | $12.79B | · | $12.95B | $13.90B | $16.12B | · | $14.82B | |
| P/E | 13.4 | 14.7 | · | 15.4 | 50.8 | 1211.0 | · | 6610.0 | 163.8 | 22.7 | · | 25.6 | 28.0 | 48.5 | · | 30.2 | |
| P/S | 4.1 | 3.8 | · | 3.5 | 3.0 | 2.9 | · | 3.2 | 3.1 | 3.6 | · | 3.7 | 4.0 | 4.9 | · | 4.5 | |
| P/B | 3.6 | 3.3 | · | 3.6 | 3.2 | 3.2 | · | 4.0 | 3.9 | 2.4 | · | 2.6 | 2.9 | 3.6 | · | 3.5 | |
| P / Tangible Book | 3.7 | 3.4 | · | 3.7 | 3.3 | 3.3 | · | 4.2 | 4.1 | 2.4 | · | 2.7 | 3.0 | 3.7 | · | 3.6 | |
| P / Cash Flow | · | 51.0 | · | · | · | 44.1 | · | · | · | 58.5 | · | · | · | -152.7 | · | · | |
| Earnings Yield | 7.4% | 6.8% | · | 6.5% | 2.0% | 0.08% | · | 0.02% | 0.61% | 4.4% | · | 3.9% | 3.6% | 2.1% | · | 3.3% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $5.14B | $4.24B | $3.70B | $3.39B | $2.99B |
| Marge d'exploitation % | 29.5% | 1.5% | — | 17.1% | 19.6% |
| Résultat net | $1.29B | $33M | $598M | $341M | $949M |
| BPA dilué | $6.41 | $0.15 | $2.65 | $1.52 | $4.27 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 3.3 | 2.0 | — | 3.5 | 3.7 |
| Ratio de liquidité réduite | 2.0 | 1.0 | — | 2.6 | 2.4 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | — | — | — | $892M | $568M |
Dernières actualités Actualités récentes mentionnant cette entreprise
Signaux de trading Signaux d'achat/vente récents avec prix d'entrée et ratio risque/récompense
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 928 déclarants · $16.2B total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 123 (-1 vs T. préc.) | 67 (-29 vs T. préc.) | 353 (+39 vs T. préc.) | 263 (-21 vs T. préc.) | -2.1M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $3 487 217 729 | 30 762 330 | 21,54% | Actions |
| Dodge & Cox | $1 355 482 475 | 11 957 326 | 8,37% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $1 249 713 401 | 11 024 289 | 7,72% | Actions |
| STATE STREET CORP | $1 102 124 009 | 9 722 336 | 6,81% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $883 198 076 | 7 791 091 | 5,46% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $472 254 570 | 4 183 857 | 2,92% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $398 135 284 | 3 512 132 | 2,46% | Actions |
| WELLINGTON MANAGEMENT GROUP LLP | $384 786 803 | 3 394 379 | 2,38% | Actions |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $311 168 439 | 2 744 958 | 1,92% | Actions |
| Robeco Institutional Asset Management B.V. | $276 795 075 | 2 441 735 | 1,71% | Actions |
| TWO SIGMA INVESTMENTS, LP | $227 123 448 | 2 003 559 | 1,40% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $201 199 603 | 1 774 874 | 1,24% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $191 845 249 | 1 692 354 | 1,19% | Actions |
| FIRST TRUST ADVISORS LP | $180 015 041 | 1 587 996 | 1,11% | Actions |
| VICTORY CAPITAL MANAGEMENT INC | $167 811 569 | 1 480 342 | 1,04% | Actions |
| Caisse de depot et placement du Quebec | $155 360 220 | 1 370 503 | 0,96% | Actions |
| AustralianSuper Pty Ltd | $135 634 220 | 1 196 491 | 0,84% | Actions |
| NORGES BANK | $126 861 970 | 1 119 107 | 0,78% | Actions |
| FMR LLC | $116 316 542 | 1 026 081 | 0,72% | Actions |
| ROYAL BANK OF CANADA | $115 263 000 | 1 016 790 | 0,71% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $106 959 694 | 943 540 | 0,66% | Actions |
| ARMISTICE CAPITAL, LLC | $102 024 567 | 900 005 | 0,63% | Actions |
| PANAGORA ASSET MANAGEMENT INC | $99 970 937 | 881 889 | 0,62% | Actions |
| GOLDMAN SACHS GROUP INC | $97 568 045 | 860 692 | 0,60% | Actions |
| VANGUARD GROUP INC | $91 396 622 | 925 348 | 0,56% | Actions |
| Sound Shore Management Inc /CT/ | $85 895 479 | 757 723 | 0,53% | Actions |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $82 953 901 | 731 774 | 0,51% | Actions |
| Gotham Asset Management, LLC | $81 567 621 | 719 545 | 0,50% | Actions |
| Pictet Asset Management Holding SA | $81 315 880 | 713 354 | 0,50% | Actions |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $75 887 460 | 768 325 | 0,47% | Actions |
| MACKENZIE FINANCIAL CORP | $71 967 956 | 634 862 | 0,44% | Actions |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $65 633 852 | 578 986 | 0,41% | Actions |
| Legal & General Group Plc | $63 331 398 | 558 675 | 0,39% | Actions |
| SEB Asset Management AB | $63 307 742 | 558 467 | 0,39% | Actions |
| GLENMEDE TRUST CO NA | $60 308 653 | 532 010 | 0,37% | Actions |
| Woodline Partners LP | $58 118 538 | 512 690 | 0,36% | Actions |
| MARSHALL WACE, LLP | $56 804 130 | 501 095 | 0,35% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $56 779 870 | 500 881 | 0,35% | Actions |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $55 184 782 | 486 810 | 0,34% | Actions |
| BlackRock, Inc. | $54 675 002 | 482 313 | 0,34% | Actions |
| Swiss National Bank | $54 058 437 | 476 874 | 0,33% | Actions |
| Glenmede Investment Management, LP | $53 145 338 | 626 640 | 0,33% | Actions |
| Vinva Investment Management Ltd | $53 069 578 | 462 843 | 0,33% | Actions |
| CANADA PENSION PLAN INVESTMENT BOARD | $50 161 800 | 442 500 | 0,31% | Actions |
| California Public Employees Retirement System | $48 730 290 | 429 872 | 0,30% | Actions |
| RHUMBLINE ADVISERS | $48 578 406 | 428 533 | 0,30% | Actions |
| IEQ CAPITAL, LLC | $48 141 997 | 424 682 | 0,30% | Actions |
| Mitsubishi UFJ Asset Management Co., Ltd. | $46 733 567 | 412 258 | 0,29% | Actions |
| Sumitomo Mitsui Trust Group, Inc. | $44 634 140 | 393 738 | 0,28% | Actions |
| Vanguard Global Advisers, LLC | $43 080 994 | 380 037 | 0,27% | Actions |
| MORGAN STANLEY | $42 894 746 | 378 394 | 0,27% | Actions |
| Swedbank AB | $42 100 431 | 371 387 | 0,26% | Actions |
| AMERICAN CENTURY COMPANIES INC | $39 177 443 | 345 602 | 0,24% | Actions |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $38 530 157 | 339 892 | 0,24% | Actions |
| CAPITAL FUND MANAGEMENT S.A. | $38 125 008 | 336 318 | 0,24% | Actions |
| VANGUARD ASSET MANAGEMENT, Ltd | $37 984 782 | 335 081 | 0,23% | Actions |
| Grantham, Mayo, Van Otterloo & Co. LLC | $36 114 682 | 318 584 | 0,22% | Actions |
| Aware Super Pty Ltd as trustee of Aware Super | $34 779 982 | 306 810 | 0,21% | Actions |
| Arbejdsmarkedets Tillaegspension | $33 826 624 | 298 400 | 0,21% | Actions |
| BARCLAYS PLC | $32 329 252 | 285 191 | 0,20% | Actions |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $32 129 398 | 283 428 | 0,20% | Actions |
| Ensign Peak Advisors, Inc | $30 602 212 | 269 956 | 0,19% | Actions |
| Illinois Municipal Retirement Fund | $29 511 916 | 260 338 | 0,18% | Actions |
| WINTON GROUP Ltd | $28 839 691 | 254 408 | 0,18% | Actions |
| PFA Pension, Forsikringsaktieselskab | $28 624 373 | 252 509 | 0,18% | Actions |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $26 717 581 | 236 172 | 0,17% | Actions |
| TODD ASSET MANAGEMENT LLC | $26 568 750 | 234 375 | 0,16% | Actions |
| BANK OF AMERICA CORP /DE/ | $25 899 133 | 228 468 | 0,16% | Actions |
| PRINCIPAL FINANCIAL GROUP INC | $24 961 078 | 220 193 | 0,15% | Actions |
| Andra AP-fonden | $24 381 598 | 259 048 | 0,15% | Actions |
| Quantinno Capital Management LP | $24 309 704 | 214 446 | 0,15% | Actions |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $24 037 194 | 212 043 | 0,15% | Actions |
| Baird Financial Group, Inc. | $23 690 539 | 208 985 | 0,15% | Actions |
| Eurizon Capital SGR S.p.A. | $23 250 000 | 204 785 | 0,14% | Actions |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $22 709 932 | 241 287 | 0,14% | Actions |
| Korea Investment CORP | $22 164 827 | 195 526 | 0,14% | Actions |
| KLP KAPITALFORVALTNING AS | $21 799 695 | 192 305 | 0,13% | Actions |
| Catalio Capital Management, LP | $21 722 837 | 191 627 | 0,13% | Actions |
| PRUDENTIAL FINANCIAL INC | $21 650 853 | 190 992 | 0,13% | Actions |
| ROYAL LONDON ASSET MANAGEMENT LTD | $21 575 016 | 190 323 | 0,13% | Actions |
| Fideuram Asset Management (Ireland) dac | $20 928 446 | 213 883 | 0,13% | Actions |
| ASHFORD CAPITAL MANAGEMENT INC | $20 651 585 | 182 177 | 0,13% | Actions |
| FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND | $20 401 285 | 179 969 | 0,13% | Actions |
| APG Asset Management N.V. | $20 193 310 | 203 661 | 0,12% | Actions |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $19 499 734 | 172 016 | 0,12% | Actions |
| SECTOR GAMMA AS | $19 356 560 | 170 753 | 0,12% | Actions |
| MARTINGALE ASSET MANAGEMENT L P | $19 137 209 | 168 818 | 0,12% | Actions |
| CWM, LLC | $19 084 906 | 202 772 | 0,12% | Actions |
| Bridgewater Associates, LP | $19 073 160 | 168 253 | 0,12% | Actions |
| ALLIANCEBERNSTEIN L.P. | $18 937 791 | 201 209 | 0,12% | Actions |
| Candriam S.C.A. | $18 443 367 | 162 854 | 0,11% | Actions |
| Focus Partners Wealth | $18 354 947 | 161 917 | 0,11% | Actions |
| DNB Asset Management AS | $18 304 239 | 161 470 | 0,11% | Actions |
| SEI INVESTMENTS CO | $18 019 140 | 158 955 | 0,11% | Actions |
| Trails Edge Capital Partners, LP | $17 570 800 | 155 000 | 0,11% | Actions |
| Jefferies Financial Group Inc. | $17 321 295 | 152 799 | 0,11% | Actions |
| SAWGRASS ASSET MANAGEMENT LLC | $17 250 671 | 152 176 | 0,11% | Actions |
| Mitsubishi UFJ Trust & Banking Corp | $17 215 756 | 151 868 | 0,11% | Actions |
| AVIVA PLC | $16 882 025 | 148 924 | 0,10% | Actions |
| Driehaus Capital Management LLC | $16 794 397 | 148 151 | 0,10% | Actions |
Initiés de la société 61 initiés · 33 dirigeants · 17 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| William Meury | Chief Executive Officer | 16 juillet 2026 A | 183 129 | 0 | 0 | $0 |
| Herve Hoppenot | Special Advisor to the CEO | 15 juillet 2025 F | 517 146 | 0 | 0 | $0 |
| Christiana Stamoulis | EVP & Chief Financial Officer | 15 juillet 2025 A | 125 759 | 0 | 0 | $0 |
| David W Gryska | Executive Vice President, CFO | 16 juillet 2018 F | 10 235 | 0 | 0 | $0 |
| David C Hastings | Chief Financial Officer | 5 juin 2014 M | 8 500 | 0 | 0 | $0 |
| Pablo J Cagnoni | President, Global Head of R&D | 19 août 2026 S | 183 200 | 0 | 7 | $-11 304 514 |
| Lee Heeson | EVP, Head of Incyte Intl | 23 juillet 2026 A | 32 778 | 0 | 0 | $0 |
| Michael James Morrissey | EVP, Head of Tech. Operations | 23 juillet 2026 A | 81 515 | 0 | 0 | $0 |
| Richard A. Hoffman | EVP & General Counsel | 16 juillet 2026 A | 16 861 | 0 | 0 | $0 |
| David H Gardner | EVP, Chief Strategy Officer | 16 juillet 2026 A | 16 824 | 0 | 0 | $0 |
| Ramitpal K Basi | EVP, Human Resources | 16 juillet 2026 A | 11 497 | 0 | 0 | $0 |
| Mohamed Khairie Issa | EVP, Head of U.S. Commercial | 16 juillet 2026 A | 71 797 | 0 | 1 | $-125 706 |
| Thomas Tray | Principal Accounting Officer | 16 juillet 2026 A | 21 699 | 0 | 1 | $-263 900 |
| Steven H Stein | CMO & Head of Late-Stage Dev. | 16 juillet 2026 A | 30 916 | 0 | 2 | $-3 407 541 |
| Sheila A. Denton | EVP & General Counsel | 15 août 2025 M | 33 200 | 0 | 0 | $0 |
| Vijay K Iyengar | EVP, GMAPPS | 16 juillet 2025 S | 40 540 | 0 | 0 | $0 |
| Barry P Flannelly | EVP & General Manager US | 16 juillet 2025 S | 35 149 | 0 | 0 | $0 |
| Matteo Trotta | EVP, GM, Dermatology US | 15 juillet 2025 A | 15 016 | 0 | 0 | $0 |
| Paula J Swain | EVP, Human Resources | 15 juillet 2025 A | 106 482 | 0 | 0 | $0 |
| Jonathan Elliott Dickinson | EVP, General Manager, Europe | 12 septembre 2024 S | 36 390 | 0 | 0 | $0 |
| Dashyant Dhanak | EVP & Chief Scientific Officer | 14 juillet 2023 A | 58 968 | 0 | 0 | $0 |
| Maria E Pasquale | EVP & General Counsel | 14 juillet 2023 A | 69 724 | 0 | 0 | $0 |
| Paul Trower | Principal Accounting Officer | 19 janvier 2022 A | 32 268 | 0 | 0 | $0 |
| Yao Wenqing | EVP, Head of Discovery Chem | 2 juillet 2021 A | 98 575 | 0 | 0 | $0 |
| Reid M Huber | EVP, Chief Scientific Officer | 16 juillet 2018 F | 34 571 | 0 | 0 | $0 |
| Eric H. Siegel | EVP, General Counsel | 13 septembre 2017 F | 21 053 | 0 | 0 | $0 |
| Richard S Levy | EVP, Chief Drug Dev Officer | 6 janvier 2016 M | 16 926 | 0 | 0 | $0 |
| James M Daly | EVP, Chief Commercial Officer | 23 juin 2015 M | 3 521 | 0 | 0 | $0 |
| Patricia S Andrews | Chief Commercial Officer | 19 janvier 2012 A | — | 0 | 0 | $0 |
| Patricia A Schreck | EVP, General Counsel | 10 mai 2011 M | 4 500 | 0 | 0 | $0 |
| Brian W Metcalf | Chief Drug Discovery Scientist | 11 avril 2011 M | 66 504 | 0 | 0 | $0 |
| Steven M. Friedman | EVP, Biology & Preclinical Dev | 18 mai 2010 A | 38 137 | 0 | 0 | $0 |
| John A Keller | Chief Business Officer | 8 février 2008 A | — | 0 | 0 | $0 |
| Paul J Clancy | Administrateur | 30 juin 2026 A | 25 635 | 0 | 1 | $-1 423 950 |
| Edmund Harrigan | Administrateur | 30 juin 2026 A | 23 019 | 0 | 0 | $0 |
| Katherine A High | Administrateur | 8 juin 2026 A | 14 983 | 0 | 0 | $0 |
| Jacqualyn A Fouse | Administrateur | 8 juin 2026 A | 20 968 | 0 | 0 | $0 |
| Jean Jacques Bienaime | Administrateur | 8 juin 2026 A | 24 424 | 0 | 0 | $0 |
| Otis W Brawley | Administrateur | 8 juin 2026 A | 12 894 | 0 | 0 | $0 |
| Susanne Schaffert | Administrateur | 12 juin 2024 A | 5 720 | 0 | 0 | $0 |
| Wendy L Dixon | Administrateur | 31 mars 2022 A | 17 768 | 0 | 0 | $0 |
| Paul A Friedman, M.D. | Administrateur | 26 mai 2020 A | 256 813 | 0 | 0 | $0 |
| Paul A Brooke | Administrateur | 31 mars 2020 A | 221 911 | 0 | 0 | $0 |
| Barry A Ariko | Administrateur | 12 mars 2015 M | 45 834 | 0 | 0 | $0 |
| Richard U De Schutter | Administrateur | 5 mars 2015 M | 92 290 | 0 | 0 | $0 |
| Roy A Whitfield | Administrateur | 17 décembre 2013 M | 666 082 | 0 | 0 | $0 |
| John F Niblack | Administrateur | 20 mai 2011 A | — | 0 | 0 | $0 |
| Fred B Craves | Administrateur | 1 juin 2005 A | 196 793 | 0 | 0 | $0 |
| INCYTE CORP | Détenteur de 10% | 25 janvier 2021 A | 3 550 000 | 0 | 0 | $0 |
| DAMIAL FOUNDATION INC | Détenteur de 10% | 11 février 2004 S | — | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 7 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker, FBB2, LLC, FBB3 LLC, FBB Associates ×21 dépôts | 11 mai 2026 | 15,60% | Amendement | Investissement passif | SEC |
| Incyte Corporation ×3 dépôts | 14 août 2023 | — | Dépôt initial | Structure du capital | SEC |
| Baker Bros. Advisors, LLC, Julian C. Baker, Felix J. Baker, FBB2, LLC, FBB Associates ×2 dépôts | 15 juin 2012 | — | Dépôt initial | — | SEC |
| Julian C. Baker, Felix J. Baker ×12 dépôts | 1 octobre 2009 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée | 25 février 2004 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée | 29 septembre 2003 | — | Dépôt initial | — | SEC |
| Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée, Personne déclarante non divulguée | 15 août 2002 | — | Dépôt initial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 225 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| IDNA · iShares Trust | 3,70% | 71 574 SH | 21 août 2026 | Quotidien |
| BRNY · EA Series Trust | 3,64% | 211 562 NS | 30 avril 2026 | N-PORT |
| FBT · First Trust Exchange-Traded Fund | 3,18% | 790 013 NS | 30 juin 2026 | N-PORT |
| PBE · Invesco Exchange-Traded Fund Trust | 3,01% | 94 349 SH | 21 août 2026 | Quotidien |
| UPGD · Invesco Exchange-Traded Fund Trust | 2,46% | 23 365 SH | 21 août 2026 | Quotidien |
| FTXH · First Trust Exchange-Traded Fund VI | 2,39% | 7 648 NS | 30 juin 2026 | N-PORT |
| BUL · Pacer Funds Trust | 2,38% | 31 787 NS | 30 avril 2026 | N-PORT |
| SAWG · ETF Series Solutions | 2,36% | 624 NS | 30 avril 2026 | N-PORT |
| FTGS · First Trust Exchange-Traded Fund | 2,30% | 253 723 NS | 30 juin 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,19% | 201 047 NS | 30 avril 2026 | N-PORT |
| FGSI · First Trust Exchange-Traded Fund IV | 1,98% | 623 NS | 30 avril 2026 | N-PORT |
| SMRI · EA Series Trust | 1,96% | 111 283 NS | 30 avril 2026 | N-PORT |
| SPGP · Invesco Exchange-Traded Fund Trust | 1,87% | 335 180 SH | 21 août 2026 | Quotidien |
| RPG · Invesco Exchange-Traded Fund Trust | 1,86% | 286 479 SH | 21 août 2026 | Quotidien |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,78% | 9 967 NS | 30 avril 2026 | N-PORT |
| IBB · iShares Trust | 1,78% | 1 479 957 SH | 21 août 2026 | Quotidien |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,75% | 112 574 SH | 21 août 2026 | Quotidien |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 1,63% | 11 747 SH | 21 août 2026 | Quotidien |
| BBP · ETFis Series Trust I | 1,59% | 9 918 NS | 30 avril 2026 | N-PORT |
| ABOT · Abacus FCF ETF Trust | 1,59% | 736 NS | 30 avril 2026 | N-PORT |
| CALF · Pacer Funds Trust | 1,55% | 561 166 NS | 30 avril 2026 | N-PORT |
| NUMG · Nushares ETF Trust | 1,44% | 53 580 NS | 30 avril 2026 | N-PORT |
| AGNG · Global X Funds | 1,36% | 11 515 NS | 31 mai 2026 | N-PORT |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 1,24% | 116 030 SH | 21 août 2026 | Quotidien |
| COWG · Pacer Funds Trust | 1,21% | 275 493 NS | 30 avril 2026 | N-PORT |
| FLOW · Global X Funds | 1,20% | 3 543 NS | 31 mai 2026 | N-PORT |
| FSCS · First Trust Exchange-Traded Fund VI | 1,15% | 5 982 NS | 30 juin 2026 | N-PORT |
| FSGS · First Trust Exchange-Traded Fund VI | 1,15% | 2 892 NS | 30 juin 2026 | N-PORT |
| DVLU · First Trust Exchange-Traded Fund VI | 1,06% | 4 278 NS | 30 juin 2026 | N-PORT |
| GURU · Global X Funds | 1,01% | 6 203 NS | 30 avril 2026 | N-PORT |
| BIB · ProShares Trust | 0,97% | 7 359 NS | 31 mai 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,94% | 51 287 NS | 30 avril 2026 | N-PORT |
| TMFX · RBB Fund, Inc. | 0,94% | 3 113 NS | 31 mai 2026 | N-PORT |
| FCFY · First Trust Exchange-Traded Fund | 0,92% | 109 NS | 30 juin 2026 | N-PORT |
| OASC · Unified Series Trust | 0,91% | 7 915 NS | 31 mai 2026 | N-PORT |
| LSVD · ADVISORS' INNER CIRCLE FUND | 0,89% | 56 482 NS | 30 avril 2026 | N-PORT |
| ROE · EA Series Trust | 0,87% | 23 347 NS | 29 mai 2026 | N-PORT |
| SPVM · Invesco Exchange-Traded Fund Trust | 0,84% | 9 113 SH | 21 août 2026 | Quotidien |
| JMID · Janus Detroit Street Trust | 0,83% | 1 595 NS | 30 avril 2026 | N-PORT |
| JOET · Virtus ETF Trust II | 0,79% | 19 541 NS | 30 avril 2026 | N-PORT |
| INFO · Harbor ETF Trust | 0,75% | 61 119 NS | 30 avril 2026 | N-PORT |
| SDG · iShares Trust | 0,72% | 10 188 SH | 21 août 2026 | Quotidien |
| CLSE · Trust for Professional Managers | 0,71% | 45 326 NS | 31 mai 2026 | N-PORT |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,64% | 85 796 NS | 30 avril 2026 | N-PORT |
| QGRO · AMERICAN CENTURY ETF TRUST | 0,64% | 146 423 NS | 31 mai 2026 | N-PORT |
| ESMV · iShares Trust | 0,54% | 339 SH | 21 août 2026 | Quotidien |
| FTQI · First Trust Exchange-Traded Fund VI | 0,54% | 44 159 NS | 30 juin 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,53% | 2 249 253 SH | 19 août 2026 | Quotidien |
| EBI · RBB Fund Trust | 0,52% | 35 279 NS | 31 mai 2026 | N-PORT |
| TECB · iShares Trust | 0,51% | 19 516 SH | 21 août 2026 | Quotidien |